We are live on ! Find out more
EMFAT

Emerald Mutual Fund Advisers Trust Portfolio holdings

AUM $2.85B
1-Year Est. Return 140.52%
This Fund
S&P 500
This Quarter Est. Return
+38.04%
1 Year Est. Return
+140.52%
3 Year Est. Return
+478.17%
5 Year Est. Return
+660.56%
10 Year Est. Return
+4,974.42%
AUM
$2.87B
AUM Growth
+$618M
Cap. Flow
+$28.8M
Cap. Flow %
1%
Top 10 Hldgs %
19.2%
Holding
366
New
53
Increased
96
Reduced
56
Closed
140

Top Buys

Rank Stock Value
1
RARE icon
Ultragenyx Pharmaceutical
RARE
+$25.9M
2
EBC icon
Eastern Bankshares
EBC
+$24.9M
3
MAX icon
MediaAlpha
MAX
+$19.8M
4
ALGM icon
Allegro MicroSystems
ALGM
+$18M
5
OCUL icon
Ocular Therapeutix
OCUL
+$16.7M

Top Sells

Rank Stock Value
1
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
+$40.5M
2
BLD
TopBuild
BLD
+$35.6M
3
TWST icon
Twist Bioscience
TWST
+$28.1M
4
QTS
QTS REALTY TRUST, INC.
QTS
+$23.3M
5
PS
Pluralsight, Inc. Class A Common Stock
PS
+$22.5M

Sector Composition

Rank Sector Weight
1 Healthcare 22.68%
2 Technology 19.33%
3 Consumer Discretionary 14.56%
4 Industrials 13.15%
5 Financials 11%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
NFE icon
26
New Fortress Energy
NFE
$96.8M
$30.3M 1.05%
565,078
-87,670
-13% -$4.01M
RARE icon
27
Ultragenyx Pharmaceutical
RARE
$2.52B
$30.2M 1.05%
+218,390
New +$25.9M
AVNT icon
28
Avient
AVNT
$4.2B
$30M 1.04%
744,567
+216,029
+41% +$7.61M
ATRC icon
29
AtriCure
ATRC
$2.07B
$28.8M 1%
518,036
+40,972
+9% +$1.77M
EBC icon
30
Eastern Bankshares
EBC
$5.24B
$28.6M 1%
+1,755,226
New +$24.9M
FIVE icon
31
Five Below
FIVE
$13.2B
$28.3M 0.98%
161,537
-16,265
-9% -$2.41M
UTHR icon
32
United Therapeutics
UTHR
$22.8B
$28.2M 0.98%
185,969
+11,923
+7% +$1.56M
QTWO icon
33
Q2 Holdings
QTWO
$3.95B
$27.4M 0.95%
216,770
+7,102
+3% +$765K
RAMP icon
34
LiveRamp
RAMP
$2.3B
$27.2M 0.95%
371,906
+73,324
+25% +$4.67M
COHR icon
35
Coherent
COHR
$73.9B
$27.2M 0.95%
357,808
-44,544
-11% -$2.64M
PLNT icon
36
Planet Fitness
PLNT
$3.99B
$26.8M 0.93%
344,843
-78,305
-19% -$5.48M
YETI icon
37
Yeti Holdings
YETI
$3.96B
$26.3M 0.92%
384,117
+15,579
+4% +$922K
KPTI icon
38
Karyopharm Therapeutics
KPTI
$45.8M
$25.7M 0.89%
110,749
+14,115
+15% +$3.27M
MODN
39
DELISTED
MODEL N, INC.
MODN
$25.7M 0.89%
719,776
-18,586
-3% -$644K
LSCC icon
40
Lattice Semiconductor
LSCC
$18.8B
$25.3M 0.88%
552,690
+18,629
+3% +$720K
CCXI
41
DELISTED
ChemoCentryx, Inc.
CCXI
$25.3M 0.88%
408,828
+44,171
+12% +$2.53M
IMVT icon
42
Immunovant
IMVT
$8.13B
$25.3M 0.88%
547,314
+44,441
+9% +$2.05M
ADUS icon
43
Addus HomeCare
ADUS
$2.24B
$25.2M 0.88%
215,036
+6,894
+3% +$712K
AZEK
44
DELISTED
The AZEK Co
AZEK
$24.7M 0.86%
641,819
+29,210
+5% +$1.05M
ARNA
45
DELISTED
Arena Pharmaceuticals Inc
ARNA
$23.7M 0.83%
308,828
+198,677
+180% +$14.9M
OCUL icon
46
Ocular Therapeutix
OCUL
$2B
$23.2M 0.81%
+1,121,628
New +$16.7M
ONTO icon
47
Onto Innovation
ONTO
$15.2B
$22.9M 0.8%
482,209
+152,729
+46% +$6.12M
SMTC icon
48
Semtech
SMTC
$13B
$22.8M 0.79%
316,872
+52,368
+20% +$3.35M
TMHC
49
DELISTED
Taylor Morrison
TMHC
$22.5M 0.78%
875,381
-130,467
-13% -$3.33M
IBP icon
50
Installed Building Products
IBP
$6.54B
$22.4M 0.78%
219,768
+8,252
+4% +$843K
1
2
3 4 5

Similar funds

SAI
Systematic Alpha Investments Princeton, New Jersey $2.84B AUM 27.03% 1-Year Est. Return
MSDF
Michael & Susan Dell Foundation New York $2.85B AUM 26.28% 1-Year Est. Return
AIP
Atlas Infrastructure Partners London, United Kingdom $2.84B AUM 4.75% 1-Year Est. Return
YC
Yarbrough Capital Franklin, Tennessee $2.85B AUM 36.22% 1-Year Est. Return
AHSSHC
Adventist Health System Sunbelt Healthcare Corp Altamonte Springs, Florida $2.86B AUM 12.86% 1-Year Est. Return
CAM
Crake Asset Management London, United Kingdom $2.86B AUM 16.35% 1-Year Est. Return
GS
GTS Securities New York $2.83B AUM 21.76% 1-Year Est. Return
ISL
Ingalls & Snyder LLC New York $2.83B AUM 21.61% 1-Year Est. Return

Emerald Mutual Fund Advisers Trust's Q4 2020 Portfolio in Review

As of Q4 2020, Emerald Mutual Fund Advisers Trust held 366 positions worth $2.87B, up 27% from $2.26B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Emerald Mutual Fund Advisers Trust's Q4 2020 filing shows 53 new, 96 increased, 56 reduced and 140 closed positions. Its largest new stake was Ultragenyx Pharmaceutical: 218,390 shares worth $30.2M. The largest sale was Horizon Therapeutics Public Limited Company Ordinary Shares, an estimated $40.5M.

By sector, the portfolio is most concentrated in Healthcare at 23% of assets, up from 21% a quarter earlier, followed by Technology and Consumer Discretionary.

  • Emerald Mutual Fund Advisers Trust's largest Q4 2020 buy was Ultragenyx Pharmaceutical: 218,390 shares worth $30.2M.
  • Emerald Mutual Fund Advisers Trust added most to Houlihan Lokey in Q4 2020, an estimated $15.8M increase.
  • Emerald Mutual Fund Advisers Trust's biggest Q4 2020 reduction was Horizon Therapeutics Public Limited Company Ordinary Shares, cutting an estimated $40.5M.
  • Emerald Mutual Fund Advisers Trust fully exited QTS REALTY TRUST, INC. in Q4 2020, selling an estimated $23.3M.
  • Emerald Mutual Fund Advisers Trust's ten largest holdings make up 19% of its $2.87B portfolio in Q4 2020.
  • Emerald Mutual Fund Advisers Trust opened 53 new positions and closed 140 in Q4 2020.
  • Emerald Mutual Fund Advisers Trust's portfolio value rose 27% quarter-over-quarter to $2.87B.

Based on Emerald Mutual Fund Advisers Trust's 13F filing for Q4 2020, filed 29 Jan 2021.